Long-term metabolic risk among children born premature or small for gestational age

Nature Reviews Endocrinology

Volumn 13, Issue 1, 2017, Pages 50-62

  Mericq, Veronica ^a   Martinez Aguayo, Alejandro ^b   Uauy, Ricardo ^a,b   Iñiguez, German ^a   Van Der Steen, Manouk ^c,d   Hokken Koelega, Anita ^c,d  

^a UNIVERSITY OF CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c Dutch Growth Research Foundation   (Netherlands)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ADOLESCENCE; ADRENAL GLAND; ADULT; ADULTHOOD; ARTIFICIAL MILK; BODY COMPOSITION; BREAST FEEDING; CHILD; CHILD GROWTH; CHILDHOOD; DISEASE ASSOCIATION; GROWTH RETARDATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN SENSITIVITY; INTRAUTERINE GROWTH RETARDATION; LIPID BLOOD LEVEL; METABOLIC DISORDER; METABOLIC RISK; NEWBORN; PREMATURITY; PRIORITY JOURNAL; PUBERTY; REVIEW; RISK; RISK REDUCTION; SMALL FOR DATE INFANT; FEMALE; GESTATIONAL AGE; METABOLIC DISEASES; METABOLISM; PREGNANCY; PREMATURE BIRTH; RISK FACTOR;

CHILD; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; METABOLIC DISEASES; PREGNANCY; PREMATURE BIRTH; RISK FACTORS;

EID: 84983087838     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2016.127     Document Type: Review

References (218)

1. Barker, D. J. et al. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36, 62-67 (1993).
2. Mericq, V. et al. Longitudinal changes in insulin sensitivity and secretion from birth to age three years in small-and appropriate-for-gestational-age children. Diabetologia 48, 2609-2614 (2005).
3. Leunissen, R. W., Kerkhof, G. F., Stijnen, T. & Hokken-Koelega, A. Timing and tempo of first-year rapid growth in relation to cardiovascular and metabolic risk profile in early adulthood. JAMA 301, 2234-2242 (2009).
4. Hattersley, A. T. et al. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat. Genet. 19, 268-270 (1998).
5. Freathy, R. M. et al. Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight. Nat. Genet. 42, 430-435 (2010).
6. Iniguez, G. et al. Expression and protein content of IGF-I and IGF-I receptor in placentas from small, adequate and large for gestational age newborns. Horm. Res. Paediatr. 73, 320-327 (2010).
7. Iniguez, G. et al. Acid-labile subunit (ALS) gene expression and protein content in human placentas: differences according to birth weight. J. Clin. Endocrinol. Metab. 96, 187-191 (2011).
8. Iniguez, G. et al. IGF-IR signal transduction protein content and its activation by IGF-I in human placentas: relationship with gestational age and birth weight. PLoS ONE 9, http: //dx. doi. org/10. 1371/journal. pone. 0102252 (2014).
9. Bourque, D. K., Avila, L., Penaherrera, M., von Dadelszen, P. & Robinson, W. P. Decreased placental methylation at the H19/IGF2 imprinting control region is associated with normotensive intrauterine growth restriction but not preeclampsia. Placenta 31, 197-202 (2010).
10. Maccani, M. A., Padbury, J. F. & Marsit, C. J. miR-16 and miR-21 expression in the placenta is associated with fetal growth. PLoS ONE 6, http: //dx. doi. org/10. 1371/journal. pone. 0021210 (2011).
11. Barker, D. J., Winter, P. D., Osmond, C., Margetts, B. & Simmonds, S. J. Weight in infancy and death from ischaemic heart disease. Lancet 2, 577-580 (1989).
12. Barker, D. J. The fetal and infant origins of adult disease. BMJ 301, 1111 (1990).
13. World Health Organisation. ICD-10 Version 2016. Certain conditions originating in the perinatal period. Ch. XV1. P05-P08 [online] http: //apps. who. int/ classifications/icd10/browse/2016/en#!/P05. 9 (WHO, 2016).
14. Sherry, B., Mei, Z., Grummer-Strawn, L. & Dietz, W. H. Evaluation of and recommendations for growth references for very low birth weight (< or = 1500 grams) infants in the United States. Pediatrics 111, 750-758 (2003).
15. World Health Organisation. Intrauterine growth retardation in newborn children. [online] http: //www. who. int/ceh/indicators/iugrnewborn. pdf (WHO, 2015).
16. Boguszewski, M. C. et al. Latin American consensus: children born small for gestational age. BMC Pediatr. 11, (2011).
17. Clayton, P. E. et al. Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. J. Clin. Endocrinol. Metab. 92, 804-810 (2007).
18. Rao, S. C., Tompkins, J. & World Health Organization. Growth curves for preterm infants. Early Hum. Dev. 83, 643-651 (2007).
19. Gelbaya, T. A. & Nardo, L. G. Customised fetal growth chart: a systematic review. J. Obstet. Gynaecol. 25, 445-450 (2005).
20. Bertino, E., Milani, S., Fabris, C. & De Curtis, M. Neonatal anthropometric charts: what they are, what they are not. Arch. Dis. Child Fetal Neonatal Ed. 92, F7-F10 (2007).
21. Ott, W. J. Intrauterine growth retardation and preterm delivery. Am. J. Obstet. Gynecol. 168, 1710-1715; discussion 1715-1717 (1993).
22. Bazaes, R. A. et al. Glucose and lipid metabolism in small for gestational age infants at 48 hours of age. Pediatrics 111, 804-809 (2003).
23. Iniguez, G. et al. Longitudinal changes in insulin-like growth factor-I, insulin sensitivity, and secretion from birth to age three years in small-for-gestational-age children. J. Clin. Endocrinol. Metab. 91, 4645-4649 (2006).
24. Ibanez, L., Ong, K., Dunger, D. B. & de Zegher, F Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children. J. Clin. Endocrinol. Metab. 91, 2153-2158 (2006).
25. Faienza, M. F. et al. Nonalcoholic fatty liver disease in prepubertal children born small for gestational age: influence of rapid weight catch-up growth. Horm. Res. Paediatr. 79, 103-109 (2013).
26. Mericq, V. et al. Serum fibroblast growth factor 21 levels are inversely associated with growth rates in infancy. Horm. Res. Paediatr. 82, 324-331 (2014).
27. Sanchez-Infantes, D. et al. Circulating FGF19 and FGF21 surge in early infancy from infra-to supra-adult concentrations. Int. J. Obes. (Lond.) 39, 742-746 (2015).
28. Soto, N. et al. Insulin sensitivity and secretion are related to catch-up growth in small-for-gestational-age infants at age 1 year: results from a prospective cohort. J. Clin. Endocrinol. Metab. 88, 3645-3650 (2003).
29. Sebastiani, G. et al. The sequence of prenatal growth restraint and post-natal catch-up growth leads to a thicker intima-media and more pre-peritoneal and hepatic fat by age 3-6 years. Pediatr. Obes. 11, 251-257 (2016).
30. Tanaka, Y. et al. Lower birth weight and visceral fat accumulation are related to hyperinsulinemia and insulin resistance in obese Japanese children. Hypertens. Res. 28, 529-536 (2005).
31. Milovanovic, I. et al. Innate small babies are metabolically healthy children. J. Clin. Endocrinol. Metab. 97, 4407-4413 (2012).
32. Iniguez, G. et al. Fasting and post-glucose ghrelin levels in SGA infants: relationships with size and weight gain at one year of age. J. Clin. Endocrinol. Metab. 87, 5830-5833 (2002).
33. Vickers, M. H., Breier, B. H., McCarthy, D. & Gluckman, P. D. Sedentary behavior during postnatal life is determined by the prenatal environment and exacerbated by postnatal hypercaloric nutrition. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, R271-R273 (2003).
34. Ikenasio-Thorpe, B. A., Breier, B. H., Vickers, M. H. & Fraser, M. Prenatal influences on susceptibility to diet-induced obesity are mediated by altered neuroendocrine gene expression. J. Endocrinol. 193, 31-37 (2007).
35. Cettour-Rose, P. et al. Redistribution of glucose from skeletal muscle to adipose tissue during catch-up fat: a link between catch-up growth and later metabolic syndrome. Diabetes 54, 751-756 (2005).
36. Crescenzo, R. et al. A role for suppressed thermogenesis favoring catch-up fat in the pathophysiology of catch-up growth. Diabetes 52, 1090-1097 (2003).
37. Schultz, N. S. et al. Impaired leptin gene expression and release in cultured preadipocytes isolated from individuals born with low birth weight. Diabetes 63, 111-121 (2014).
38. Joseph, R. et al. ACSL1 Is associated with fetal programming of insulin sensitivity and cellular lipid content. Mol. Endocrinol. 29, 909-920 (2015).
39. Wang, X., Cui, Y., Tong, X., Ye, H. & Li, S. Glucose and lipid metabolism in small-for-gestational-age infants at 72 hours of age. J. Clin. Endocrinol. Metab. 92, 681-684 (2007).
40. Hoe, F. M. et al. Clinical features and insulin regulation in infants with a syndrome of prolonged neonatal hyperinsulinism. J. Pediatr. 148, 207-212 (2006).
41. Beltrand, J. et al. Catch-up growth following fetal growth restriction promotes rapid restoration of fat mass but without metabolic consequences at one year of age. PLoS ONE 4, http: //dx. doi. org/10. 1371/ journal. pone. 0005343 (2009).
42. Linares, J. et al. The effects of pre-pregnancy BMI and maternal factors on the timing of adiposity rebound in offspring. Obes. (Silver Spring) 24, 1313-1319 (2016).
43. Hokken-Koelega, A. C. et al. Children born small for gestational age: do they catch up? Pediatr. Res. 38, 267-271 (1995).
44. Albertsson-Wikland, K., Boguszewski, M. & Karlberg, J. Children born small-for-gestational age: postnatal growth and hormonal status. Horm. Res. 49 (Suppl. 2), 7-13 (1998).
45. Ranke, M. B. et al. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age. Horm. Res. 64, 68-76 (2005).
46. Edghill, E. L. et al. Insulin mutation screening in 1, 044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 57, 1034-1042 (2008).
47. Begemann, M. et al. Paternally inherited IGF2 mutation and growth restriction. N. Engl. J. Med. 373, 349-356 (2015).
48. Bazaes, R. A. et al. Determinants of insulin sensitivity and secretion in very-low-birth-weight children. J. Clin. Endocrinol. Metab. 89, 1267-1272 (2004).
49. Veening, M. A., Van Weissenbruch, M. M. & Delemarre-Van De Waal, H. A. Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age. J. Clin. Endocrinol. Metab. 87, 4657-4661 (2002).
50. Hofman, P. L. et al. Insulin resistance in short children with intrauterine growth retardation. J. Clin. Endocrinol. Metab. 82, 402-406 (1997).
51. Lyall, H., Burchell, A., Howie, P. W., Ogston, S. & Hume, R. Early detection of metabolic abnormalities in preterm infants impaired by disorders of blood glucose concentrations. Clin. Chem. 40, 526-530 (1994).
52. Shelley, H. J., Bassett, J. M. & Milner, R. D. Control of carbohydrate metabolism in the fetus and newborn. Br. Med. Bull. 31, 37-43 (1975).
53. Hume, R. & Burchell, A. Abnormal expression of glucose-6-phosphatase in preterm infants. Arch. Dis. Child. 68, 202-204 (1993).
54. Hawdon, J. M., Ward Platt, M. P. & Aynsley-Green, A. Patterns of metabolic adaptation for preterm and term infants in the first neonatal week. Arch. Dis. Child. 67, 357-365 (1992).
55. Hey, E. Hyperglycaemia and the very preterm baby. Semin. Fetal Neonatal Med. 10, 377-387 (2005).
56. Hawdon, J. M., Aynsley-Green, A., Alberti, K. G. & Ward Platt, M. P. The role of pancreatic insulin secretion in neonatal glucoregulation. I. Healthy term and preterm infants. Arch. Dis. Child. 68, 274-279 (1993).
57. Farrag, H. M. et al. Persistent glucose production and greater peripheral sensitivity to insulin in the neonate versus the adult. Am. J. Physiol. 272, E86-E93 (1997).
58. Leipala, J. A., Raivio, K. O., Sarnesto, A., Panteleon, A. & Fellman, V. Intrauterine growth restriction and postnatal steroid treatment effects on insulin sensitivity in preterm neonates. J. Pediatr. 141, 472-476 (2002).
59. Gray, I. P., Cooper, P. A., Cory, B. J., Toman, M. & Crowther, N. J. The intrauterine environment is a strong determinant of glucose tolerance during the neonatal period, even in prematurity. J. Clin. Endocrinol. Metab. 87, 4252-4256 (2002).
60. Fewtrell, M. S. et al. Effects of size at birth, gestational age and early growth in preterm infants on glucose and insulin concentrations at 9-12 years. Diabetologia 43, 714-717 (2000).
61. Hofman, P. L. et al. Premature birth and later insulin resistance. N. Engl. J. Med. 351, 2179-2186 (2004).
62. Bavdekar, A. et al. Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both? Diabetes 48, 2422-2429 (1999).
63. Finken, M. J. et al. Preterm birth and later insulin resistance: effects of birth weight and postnatal growth in a population based longitudinal study from birth into adult life. Diabetologia 49, 478-485 (2006).
64. Ong, K. K. et al. Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels. Diabetologia 47, 1064-1070 (2004).
65. Kajantie, E. et al. Insulin sensitivity and secretory response in adults born preterm: the Helsinki Study of Very Low Birth Weight Adults. J. Clin. Endocrinol. Metab. 100, 244-250 (2015).
66. Lucas, A. et al. Randomized trial of nutrient-enriched formula versus standard formula for postdischarge preterm infants. Pediatrics 108, 703-711 (2001).
67. Regan, F. M., Cutfield, W. S., Jefferies, C., Robinson, E. & Hofman, P. L. The impact of early nutrition in premature infants on later childhood insulin sensitivity and growth. Pediatrics 118, 1943-1949 (2006).
68. Gale, C. R., Martyn, C. N., Kellingray, S., Eastell, R. & Cooper, C. Intrauterine programming of adult body composition. J. Clin. Endocrinol. Metab. 86, 267-272 (2001).
69. Uthaya, S. et al. Altered adiposity after extremely preterm birth. Pediatr. Res. 57, 211-215 (2005).
70. Tappy, L. & D'Alessio, D. Obesity and insulin resistance: is it due to body fat, energy balance, or gut factors? Curr. Opin. Clin. Nutr. Metab. Care 9, 455-457 (2006).
71. Cooke, R. J. et al. Body composition of preterm infants during infancy. Arch. Dis. Child. Fetal Neonatal Ed. 80, F188-F191 (1999).
72. Fonseca, V. M., Sichieri, R., Moreira, M. E. & Moura, A. S. Early postnatal growth in preterm infants and cord blood leptin. J. Perinatol. 24, 751-756 (2004).
73. Sepulveda, C. et al. Differences in body composition and resting energy expenditure in childhood in preterm children born with very low birth weight. Horm. Res. Paediatr. 79, 347-355 (2013).
74. Latal-Hajnal, B., von Siebenthal, K., Kovari, H., Bucher, H. U. & Largo, R. H. Postnatal growth in VLBW infants: significant association with neurodevelopmental outcome. J. Pediatr. 143, 163-170 (2003).
75. Okuma, C. et al. Microstructural brain and multivoxel spectroscopy in very low birth weight infants related to insulin-like growth factor concentration and early growth. Horm. Res. Paediatr. 79, 197-207 (2013).
76. Ghirri, P. et al. Adrenarche, pubertal development, age at menarche and final height of full-term, born small for gestational age (SGA) girls. Gynecol. Endocrinol. 15, 91-97 (2001).
77. Ibanez, L., Dimartino-Nardi, J., Potau, N. & Saenger, P. Premature adrenarche-normal variant or forerunner of adult disease? Endocr. Rev. 21, 671-696 (2000).
78. Ibanez, L., Potau, N., Marcos, M. V. & de Zegher, F. Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestational age. J. Clin. Endocrinol. Metab. 84, 4739-4741 (1999).
79. Oppenheimer, E., Linder, B. & DiMartino-Nardi, J. Decreased insulin sensitivity in prepubertal girls with premature adrenarche and acanthosis nigricans. J. Clin. Endocrinol. Metab. 80, 614-618 (1995).
80. Voutilainen, R. & Jaaskelainen, J. Premature adrenarche: etiology, clinical findings, and consequences. J. Steroid Biochem. Mol. Biol. 145, 226-236 (2015).
81. Denburg, M. R. et al. Insulin sensitivity and the insulin-like growth factor system in prepubertal boys with premature adrenarche. J. Clin. Endocrinol. Metab. 87, 5604-5609 (2002).
82. Ibanez, L., Potau, N., Francois, I. & de Zegher, F. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J. Clin. Endocrinol. Metab. 83, 3558-3562 (1998).
83. Ibanez, L. et al. Polycystic ovaries after precocious pubarche: relation to prenatal growth. Hum. Reprod. 22, 395-400 (2007).
84. Ibanez, L. et al. Growth hormone, insulin-like growth factor-I axis, and insulin secretion in hyperandrogenic adolescents. Fertil. Steril. 64, 1113-1119 (1995).
85. Guercio, G., Rivarola, M. A., Chaler, E., Maceiras, M. & Belgorosky, A. Relationship between the growth hormone/insulin-like growth factor-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls. J. Clin. Endocrinol. Metab. 88, 1389-1393 (2003).
86. Ibanez, L., Lopez-Bermejo, A., Diaz, M. & de Zegher, F. Catch-up growth in girls born small for gestational age precedes childhood progression to high adiposity. Fertil. Steril. 96, 220-223 (2011).
87. Jaquet, D., Deghmoun, S., Chevenne, D., Czernichow, P. & Levy-Marchal, C. Low serum adiponectin levels in subjects born small for gestational age: impact on insulin sensitivity. Int. J. Obes. (Lond.) 30, 83-87 (2006).
88. Verkauskiene, R., Petraitiene, I. & Albertsson Wikland, K. Puberty in children born small for gestational age. Horm. Res. Paediatr. 80, 69-77 (2013).
89. Estourgie-van Burk, G. F., Bartels, M. & Boomsma, D. I. A twin-sibling study on early growth and hormone levels in adolescents. Behav. Genet. 45, 283-293 (2015).
90. Oron, T. et al. Interrelationship of extent of precocious adrenarche in appropriate for gestational age girls with clinical outcome. J. Pediatr. 160, 308-313 (2012).
91. Albertsson-Wikland, K. & Karlberg, J. Natural growth in children born small for gestational age with and without catch-up growth. Acta Paediatr. Suppl. 399, 64-70 (1994).
92. Karlberg, J., Kwan, C. W., Gelander, L. & Albertsson-Wikland, K. Pubertal growth assessment. Horm. Res. 60, 27-35 (2003).
93. Persson, I. et al. Influence of perinatal factors on the onset of puberty in boys and girls: implications for interpretation of link with risk of long term diseases. Am. J. Epidemiol. 150, 747-755 (1999).
94. Lazar, L., Pollak, U., Kalter-Leibovici, O., Pertzelan, A. & Phillip, M. Pubertal course of persistently short children born small for gestational age (SGA) compared with idiopathic short children born appropriate for gestational age (AGA). Eur. J. Endocrinol. 149, 425-432 (2003).
95. Sloboda, D. M., Hart, R., Doherty, D. A., Pennell, C. E. & Hickey, M. Age at menarche: Influences of prenatal and postnatal growth. J. Clin. Endocrinol. Metab. 92, 46-50 (2007).
96. Chaudhari, S., Otiv, M., Hoge, M., Pandit, A. & Mote, A. Growth and sexual maturation of low birth weight infants at early adolescence. Indian Pediatr. 45, 191-198 (2008).
97. Ibanez, L., Jimenez, R. & de Zegher, F. Early puberty-menarche after precocious pubarche: relation to prenatal growth. Pediatrics 117, 117-121 (2006).
98. Labarta, J. I. et al. Growth and growth hormone treatment in short stature children born small for gestational age. Pediatr. Endocrinol. Rev. 6 (Suppl. 3), 350-357 (2009).
99. Hernandez, M. I. et al. Accelerated early pubertal progression, ovarian morphology, and ovarian function in prospectively followed low birth weight (LBW) girls. J. Pediatr. Endocrinol. Metab. 26, 223-230 (2013).
100. Hui, L. L., Leung, G. M., Wong, M. Y., Lam, T. H. & Schooling, C. M. Small for gestational age and age at puberty: evidence from Hong Kong's "Children of 1997" birth cohort. Am. J. Epidemiol. 176, 785-793 (2012).
101. Ibanez, L., Potau, N. & de Zegher, F. Ovarian hyporesponsiveness to follicle stimulating hormone in adolescent girls born small for gestational age. J. Clin. Endocrinol. Metab. 85, 2624-2626 (2000).
102. Ibanez, L., Potau, N., Enriquez, G. & de Zegher, F. Reduced uterine and ovarian size in adolescent girls born small for gestational age. Pediatr. Res. 47, 575-577 (2000).
103. Hernandez, M. I. et al. Comparison of clinical, ultrasonographic, and biochemical differences at the beginning of puberty in healthy girls born either small for gestational age or appropriate for gestational age: preliminary results. J. Clin. Endocrinol. Metab. 91, 3377-3381 (2006).
104. Potau, N., Ibanez, L., Rique, S., Sanchez-Ufarte, C. & de Zegher, F. Pronounced adrenarche and precocious pubarche in boys. Horm. Res. 51, 238-241 (1999).
105. Boonstra, V. H., Weber, R. F., de Jong, F. H. & Hokken-Koelega, A. C. Testis function in prepubertal boys and young men born small for gestational age. Horm. Res. 70, 357-363 (2008).
106. Jensen, R. B. et al. Pituitary-gonadal function in adolescent males born appropriate or small for gestational age with or without intrauterine growth restriction. J. Clin. Endocrinol. Metab. 92, 1353-1357 (2007).
107. Wehkalampi, K. et al. Advanced pubertal growth spurt in subjects born preterm: the Helsinki study of very low birth weight adults. J. Clin. Endocrinol. Metab. 96, 525-533 (2011).
108. Kuiri-Hanninen, T. et al. Postnatal developmental changes in the pituitary-ovarian axis in preterm and term infant girls. J. Clin. Endocrinol. Metab. 96, 3432-3439 (2011).
109. Kuiri-Hanninen, T. et al. Increased activity of the hypothalamic-pituitary-testicular axis in infancy results in increased androgen action in premature boys. J. Clin. Endocrinol. Metab. 96, 98-105 (2011).
110. Barker, D. J. et al. Fetal nutrition and cardiovascular disease in adult life. Lancet 341, 938-941 (1993).
111. Goland, R. S. et al. Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses. J. Clin. Endocrinol. Metab. 77, 1174-1179 (1993).
112. Moisiadis, V. G. & Matthews, S. G. Glucocorticoids and fetal programming part 2: Mechanisms. Nat. Rev. Endocrinol. 10, 403-411 (2014).
113. Phillips, D. I. et al. Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome? J. Clin. Endocrinol. Metab. 83, 757-760 (1998).
114. Cottrell, E. C. & Seckl, J. R. Prenatal stress, glucocorticoids and the programming of adult disease. Front. Behav. Neurosci. 3, http: //dx. doi. org/10. 3389/ neuro. 08. 019. 2009 (2009).
115. Seckl, J. R. Prenatal glucocorticoids and long-term programming. Eur. J. Endocrinol. 151 (Suppl. 3), U49-U62 (2004).
116. Assadi, F. The epidemic of pediatric chronic kidney disease: the danger of skepticism. J. Nephropathol. 1, 61-64 (2012).
117. Raitakari, O. T. et al. Pulse pressure in youth and carotid intima-media thickness in adulthood: the cardiovascular risk in young Finns study. Stroke 40, 1519-1521 (2009).
118. Bayrakci, U. S., Schaefer, F., Duzova, A., Yigit, S. & Bakkaloglu, A. Abnormal circadian blood pressure regulation in children born preterm. J. Pediatr. 151, 399-403 (2007).
119. Franco, M. C., Christofalo, D. M., Sawaya, A. L., Ajzen, S. A. & Sesso, R. Effects of low birth weight in 8-to 13-year-old children: implications in endothelial function and uric acid levels. Hypertension 48, 45-50 (2006).
120. Leeson, C. P., Kattenhorn, M., Morley, R., Lucas, A. & Deanfield, J. E. Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life. Circulation 103, 1264-1268 (2001).
121. Martinez-Aguayo, A. et al. Birth weight is inversely associated with blood pressure and serum aldosterone and cortisol levels in children. Clin. Endocrinol. (Oxf.) 76, 713-718 (2012).
122. Gustafsson, P. E., Janlert, U., Theorell, T. & Hammarstrom, A. Is body size at birth related to circadian salivary cortisol levels in adulthood? Results from a longitudinal cohort study. BMC Public Health 10, http: //dx. doi. org/10. 1186/1471-2458-10-346 (2010).
123. Vehaskari, V. M., Aviles, D. H. & Manning, J. Prenatal programming of adult hypertension in the rat. Kidney Int. 59, 238-245 (2001).
124. Franco, M. C. et al. Circulating renin-angiotensin system and catecholamines in childhood: is there a role for birthweight? Clin. Sci. (Lond.) 114, 375-380 (2008).
125. Arends, N. J. et al. Reduced insulin sensitivity and the presence of cardiovascular risk factors in short prepubertal children born small for gestational age (SGA). Clin. Endocrinol. (Oxf.) 62, 44-50 (2005).
126. Martinez-Aguayo, A. et al. Comparison of leptin levels, body composition and insulin sensitivity and secretion by OGTT in healthy, early pubertal girls born at either appropriate-or small-for-gestational age. Clin. Endocrinol. (Oxf.) 67, 526-532 (2007).
127. Miras, M. et al. Serum levels of adiponectin and leptin in children born small for gestational age: relation to insulin sensitivity parameters. J. Pediatr. Endocrinol. Metab. 23, 463-471 (2010).
128. Rocchini, A. P. Obesity hypertension, salt sensitivity and insulin resistance. Nutr. Metab. Cardiovasc. Dis. 10, 287-294 (2000).
129. Cho, W. K. & Suh, B. K. Catch-up growth and catch-up fat in children born small for gestational age. Korean J. Pediatr. 59, 1-7 (2016).
130. Shah, A. B., Hashmi, S. S., Sahulee, R., Pannu, H. & Gupta-Malhotra, M. Characteristics of systemic hypertension in preterm children. J. Clin. Hypertens. (Greenwich) 17, 364-370 (2015).
131. Kwinta, P. et al. From a regional cohort of extremely low birth weight infants: cardiac function at the age of 7 years. Neonatology 103, 287-292 (2013).
132. Ohkubo, T. et al. Relation between nocturnal decline in blood pressure and mortality. The Ohasama Study. Am. J. Hypertens. 10, 1201-1207 (1997).
133. Verdecchia, P. et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 24, 793-801 (1994).
134. Roberts, G., Lee, K. J., Cheong, J. L. Doyle, L. W. & Victorian Infant Collaborative Study Group. Higher ambulatory blood pressure at 18 years in adolescents born less than 28 weeks' gestation in the 1990s compared with term controls. J. Hypertens. 32, 620-626 (2014).
135. Cook, N. R., Cohen, J., Hebert, P. R., Taylor, J. O. & Hennekens, C. H. Implications of small reductions in diastolic blood pressure for primary prevention. Arch. Intern. Med. 155, 701-709 (1995).
136. Willemsen, R. H., de Kort, S. W., van der Kaay, D. C. & Hokken-Koelega, A. C. Independent effects of prematurity on metabolic and cardiovascular risk factors in short small-for-gestational-age children. J. Clin. Endocrinol. Metab. 93, 452-458 (2008).
137. Sipola-Leppanen, M. et al. Cardiovascular risk factors in adolescents born preterm. Pediatrics 134, e1072-e1081 (2014).
138. Kerkhof, G. F., Breukhoven, P. E., Leunissen, R. W., Willemsen, R. H. & Hokken-Koelega, A. C. Does preterm birth influence cardiovascular risk in early adulthood? J. Pediatr. 161, 390-396. e1 (2012).
139. Lee, H., Dichtl, S., Mormanova, Z., Dalla Pozza, R. & Genzel-Boroviczeny, O. In adolescence, extreme prematurity is associated with significant changes in the microvasculature, elevated blood pressure and increased carotid intima-media thickness. Arch. Dis. Child. 99, 907-911 (2014).
140. Abitbol, C. L. & Rodriguez, M. M. The long-term renal and cardiovascular consequences of prematurity. Nat. Rev. Nephrol. 8, 265-274 (2012).
141. Vohr, B. R., Allan, W., Katz, K. H., Schneider, K. C. & Ment, L. R. Early predictors of hypertension in prematurely born adolescents. Acta Paediatr. 99, 1812-1818 (2010).
142. Irving, R. J., Belton, N. R., Elton, R. A. & Walker, B. R. Adult cardiovascular risk factors in premature babies. Lancet 355, 2135-2136 (2000).
143. Bonamy, A. K. et al. Preterm birth contributes to increased vascular resistance and higher blood pressure in adolescent girls. Pediatr. Res. 58, 845-849 (2005).
144. Belfort, M. B., Martin, C. R., Smith, V. C., Gillman, M. W. & McCormick, M. C. Infant weight gain and school-age blood pressure and cognition in former preterm infants. Pediatrics 125, e1419-e1426 (2010).
145. Van Dijk, M., Bannink, E. M., Van Pareren, Y. K., Mulder, P. G. & Hokken-Koelega, A. C. Risk factors for diabetes mellitus type 2 and metabolic syndrome are comparable for previously growth hormone-treated young adults born small for gestational age (SGA) and untreated short SGA controls. J. Clin. Endocrinol. Metab. 92, 160-165 (2007).
146. Leunissen, R. W., Kerkhof, G. F., Stijnen, T. & Hokken-Koelega, A. C. Effect of birth size and catch-up growth on adult blood pressure and carotid intima-media thickness. Horm. Res. Paediatr. 77, 394-401 (2012).
147. Breukhoven, P. E., Kerkhof, G. F., Van Dijk, M. & Hokken-Koelega, A. C. Long-term impact of GH treatment during childhood on body composition and fat distribution in young adults born SGA. J. Clin. Endocrinol. Metab. 96, 3710-3716 (2011).
148. Leunissen, R. W., Stijnen, T. & Hokken-Koelega, A. C. Influence of birth size on body composition in early adulthood: the programming factors for growth and metabolism (PROGRAM)-study. Clin. Endocrinol. (Oxf.) 70, 245-251 (2009).
149. Fabricius-Bjerre, S. et al. Impact of birth weight and early infant weight gain on insulin resistance and associated cardiovascular risk factors in adolescence. PLoS ONE 6, http: //dx. doi. org/10. 1371/journal. pone. 0020595 (2011).
150. Leger, J. et al. Reduced final height and indications for insulin resistance in 20 year olds born small for gestational age: Regional cohort study. BMJ 315, 341-347 (1997).
151. Potau, N. et al. Hyperinsulinemia in pre-and post-pubertal children born small for gestational age. Horm. Res. 56, 146-150 (2001).
152. Leunissen, R. W. et al. Fat mass accumulation during childhood determines insulin sensitivity in early adulthood. J. Clin. Endocrinol. Metab. 93, 445-451 (2008).
153. Verkauskiene, R. et al. Birth weight and long-term metabolic outcomes: does the definition of smallness matter? Horm. Res. 70, 309-315 (2008).
154. Meas, T. et al. Independent effects of weight gain and fetal programming on metabolic complications in adults born small for gestational age. Diabetologia 53, 907-913 (2010).
155. Chiavaroli, V. et al. Progression of cardio-metabolic risk factors in subjects born small and large for gestational age. PLoS ONE 9, http: //dx. doi. org/10. 1371/journal. pone. 0104278 (2014).
156. Eriksson, J., Forsen, T., Tuomilehto, J., Osmond, C. & Barker, D. Fetal and childhood growth and hypertension in adult life. Hypertension 36, 790-794 (2000).
157. Forsen, T. et al. The fetal and childhood growth of persons who develop type 2 diabetes. Ann. Intern. Med. 133, 176-182 (2000).
158. Eriksson, J. G., Forsen, T., Tuomilehto, J., Osmond, C. & Barker, D. J. Early growth and coronary heart disease in later life: longitudinal study. BMJ 322, 949-953 (2001).
159. Keijzer-Veen, M. G., Dulger, A., Dekker, F. W., Nauta, J. & van der Heijden, B. J. Very preterm birth is a risk factor for increased systolic blood pressure at a young adult age. Pediatr. Nephrol. 25, 509-516 (2010).
160. Rossi, P. et al. Respective roles of preterm birth and fetal growth restriction in blood pressure and arterial stiffness in adolescence. J. Adolesc. Health 48, 520-522 (2011).
161. Kerkhof, G. F., Breukhoven, P. E., Leunissen, R. W., Willemsen, R. H. & Hokken-Koelega, A. C. Does preterm birth influence cardiovascular risk in early adulthood? J. Pediatr. 161, 390-396. e391 (2012).
162. Sipola-Leppänen, M. et al. Cardiovascular risk factors in adolescents born preterm. Pediatrics 134, e1072-e1081 (2014).
163. Tauzin, L. et al. Increased systemic blood pressure and arterial stiffness in young adults born prematurely. J. Dev. Orig. Health Dis. 5, 448-452 (2014).
164. Sipola-Leppänen, M. et al. Cardiometabolic risk factors in young adults who were born preterm. Am. J. Epidemiol. 181, 861-873 (2015).
165. Lee, H., Dichtl, S., Mormanova, Z., Dalla Pozza, R. & Genzel-Boroviczeny, O. In adolescence, extreme prematurity is associated with significant changes in the microvasculature, elevated blood pressure and increased carotid intima-media thickness. Arch. Dis. Child. Educ. Pract. Ed. 99, 907-911 (2014).
166. Ueda, P. et al. Cerebrovascular and ischemic heart disease in young adults born preterm: A population-based Swedish cohort study. Eur. J. Epidemiol. 29, 253-260 (2014).
167. Kajantie, E., Osmond, C. & Eriksson, J. G. Coronary heart disease and stroke in adults born preterm-The Helsinki Birth Cohort Study. Paediatr. Perinat. Epidemiol. 29, 515-519 (2015).
168. Willemsen, R. H., Leunissen, R. W., Stijnen, T. & Hokken-Koelega, A. C. Prematurity is not associated with reduced insulin sensitivity in adulthood. J. Clin. Endocrinol. Metab. 94, 1695-1700 (2009).
169. Breukhoven, P. E., Kerkhof, G. F., Willemsen, R. H. & Hokken-Koelega, A. C. Fat mass and lipid profile in young adults born preterm. J. Clin. Endocrinol. Metab. 97, 1294-1302 (2012).
170. Hovi, P. et al. Glucose regulation in young adults with very low birth weight. N. Engl. J. Med. 356, 2053-2063 (2007).
171. Kerkhof, G. F., Willemsen, R. H., Leunissen, R. W., Breukhoven, P. E. & Hokken-Koelega, A. C. Health profile of young adults born preterm: negative effects of rapid weight gain in early life. J. Clin. Endocrinol. Metab. 97, 4498-4506 (2012).
172. Breij, L. M., Kerkhof, G. F. & Hokken-Koelega, A. C. Risk for nonalcoholic fatty liver disease in young adults born preterm. Horm. Res. Paediatr. 84, 199-205 (2015).
173. Carel, J. C., Chatelain, P., Rochiccioli, P. & Chaussain, J. L. Improvement in adult height after growth hormone treatment in adolescents with short stature born small for gestational age: results of a randomized controlled study. J. Clin. Endocrinol. Metab. 88, 1587-1593 (2003).
174. Van Pareren, Y. et al. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial. J. Clin. Endocrinol. Metab. 88, 3584-3590 (2003).
175. Dahlgren, J., Wikland, K. A., & Swedish Study Group for Growth Hormone Treatment. Final height in short children born small for gestational age treated with growth hormone. Pediatr. Res. 57, 216-222 (2005).
176. de Zegher, F., Ong, K. K., Ibanez, L. & Dunger, D. B. Growth hormone therapy in short children born small for gestational age. Horm. Res. 65 (Suppl. 3), 145-152 (2006).
177. Sas, T., Mulder, P. & Hokken-Koelega, A. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency. J. Clin. Endocrinol. Metab. 85, 3786-3792 (2000).
178. Van Pareren, Y. et al. Effect of discontinuation of growth hormone treatment on risk factors for cardiovascular disease in adolescents born small for gestational age. J. Clin. Endocrinol. Metab. 88, 347-353 (2003).
179. Knop, C., Wolters, B., Lass, N., Wunsch, R. & Reinehr, T. Carotid intima-media thickness in children treated with growth hormone. J. Pediatr. Endocrinol. Metab. 28, 985-991 (2015).
180. Richelsen, B. Action of growth hormone in adipose tissue. Horm. Res. 48 (Suppl. 5), 105-110 (1997).
181. Mukherjee, A., Murray, R. D. & Shalet, S. M. Impact of growth hormone status on body composition and the skeleton. Horm. Res. 62 (Suppl. 3), 35-41 (2004).
182. Willemsen, R. H., Willemsen, S. P. & Hokken-Koelega, A. C. Longitudinal changes in insulin sensitivity and body composition of small-for-gestational-age adolescents after cessation of growth hormone treatment. J. Clin. Endocrinol. Metab. 93, 3449-3454 (2008).
183. Bratusch-Marrain, P. R., Smith, D. & DeFronzo, R. A. The effect of growth hormone on glucose metabolism and insulin secretion in man. J. Clin. Endocrinol. Metab. 55, 973-982 (1982).
184. Heptulla, R. A. et al. Decreased insulin sensitivity and compensatory hyperinsulinemia after hormone treatment in children with short stature. J. Clin. Endocrinol. Metab. 82, 3234-3238 (1997).
185. Cutfield, W. S. et al. Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment. Lancet 355, 610-613 (2000).
186. Sas, T. et al. Carbohydrate metabolism during long-term growth hormone treatment in children with short stature born small for gestational age. Clin. Endocrinol. (Oxf.) 54, 243-251 (2001).
187. Cutfield, W. S. et al. Reduced insulin sensitivity during growth hormone therapy for short children born small for gestational age. J. Pediatr. 142, 113-116 (2003).
188. Chatelain, P., Crabbe, R., Saunders, H. & von Holtey, M. Changes in insulin sensitivity and glucose metabolism during therapy with recombinant human growth hormone in short children born small for gestational age show a negative correlation with baseline measurements. J. Pediatr. Endocrinol. Metab. 21, 329-338 (2008).
189. Lem, A. J. et al. Adult height in children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial. J. Clin. Endocrinol. Metab 97, 4096-4105 (2012).
190. Van Der Steen, M. et al. Metabolic health in short children born small for gestational age treated with growth hormone and gonadotropin-releasing hormone analog: results of a randomized, dose-response trial. J. Clin. Endocrinol. Metab. 100, 3725-3734 (2015).
191. Black, R. E. et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 382, 427-451 (2013).
192. Ibanez, L., Lopez-Bermejo, A., Diaz, M., Marcos, M. V. & de Zegher, F. Metformin treatment for four years to reduce total and visceral fat in low birth weight girls with precocious pubarche. J. Clin. Endocrinol. Metab. 93, 1841-1845 (2008).
193. Ibanez, L., Lopez-Bermejo, A., Diaz, M., Marcos, M. V. & de Zegher, F. Pubertal metformin therapy to reduce total, visceral, and hepatic adiposity. J. Pediatr. 156, 98-102 e1 (2010).
194. Diaz, M., Bassols, J., Lopez-Bermejo, A., de Zegher, F. & Ibanez, L. Metformin treatment to reduce central adiposity after prenatal growth restraint: a placebo-controlled pilot study in prepubertal children. Pediatr. Diabetes 16, 538-545 (2015).
195. Han, J., Xu, J., Epstein, P. N. & Liu, Y. Q. Long-term effect of maternal obesity on pancreatic cells of offspring: reduced cell adaptation to high glucose and high-fat diet challenges in adult female mouse offspring. Diabetologia 48, 1810-1818 (2005).
196. Cordero, P., Campion, J., Milagro, F. I. & Martinez, J. A. Transcriptomic and epigenetic changes in early liver steatosis associated to obesity: effect of dietary methyl donor supplementation. Mol. Genet. Metab. 110, 388-395 (2013).
197. Wang, H., Storlien, L. H. & Huang, X. F. Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression. Am. J. Physiol. Endocrinol. Metab. 282, E1352-E1359 (2002).
198. Harder, T., Bergmann, R., Kallischnigg, G. & Plagemann, A. Duration of breastfeeding and risk of overweight: a meta-analysis. Am. J. Epidemiol. 162, 397-403 (2005).
199. Mericq, V. et al. Maternally transmitted and food-derived glycotoxins: a factor preconditioning the young to diabetes? Diabetes Care 33, 2232-2237 (2010).
200. Rolland-Cachera, M. F., Deheeger, M., Akrout, M. & Bellisle, F. Influence of macronutrients on adiposity development: a follow up study of nutrition and growth from 10 months to 8 years of age. Int. J. Obes. Relat. Metab. Disord. 19, 573-578 (1995).
201. Koletzko, B. et al. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. Am. J. Clin. Nutr. 89, 1836-1845 (2009).
202. Socha, P. et al. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. Am. J. Clin. Nutr. 94, (Suppl. 6) 1776S-1784S (2011).
203. Kirchberg, F. F. et al. Dietary protein intake affects amino acid and acylcarnitine metabolism in infants aged 6 months. J. Clin. Endocrinol. Metab. 100, 149-158 (2015).
204. Singhal, A. et al. Nutrition in infancy and long-term risk of obesity: evidence from 2 randomized controlled trials. Am. J. Clin. Nutr. 92, 1133-1144 (2010).
205. O'Connor, D. L. et al. Growth and nutrient intakes of human milk-fed preterm infants provided with extra energy and nutrients after hospital discharge. Pediatrics 121, 766-776 (2008).
206. Koo, W. W. & Hockman, E. M. Posthospital discharge feeding for preterm infants: effects of standard compared with enriched milk formula on growth, bone mass, and body composition. Am. J. Clin. Nutr. 84, 1357-1364 (2006).
207. Agostoni, C. et al. Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J. Pediatr. Gastroenterol. Nutr. 50, 85-91 (2010).
208. Singhal, A., Fewtrell, M., Cole, T. J. & Lucas, A. Low nutrient intake and early growth for later insulin resistance in adolescents born preterm. Lancet 361, 1089-1097 (2003).
209. Pittaluga, E. et al. Benefits of supplemented preterm formulas on insulin sensitivity and body composition after discharge from the neonatal intensive care unit. J. Pediatr. 159, 926-932. e2 (2011).
210. Clandinin, M. T. et al. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum. Dev. 4, 121-129 (1980).
211. Jiao, J. et al. Effect of-3 PUFA supplementation on cognitive function throughout the life span from infancy to old age: a systematic review and meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 100, 1422-1436 (2014).
212. Ruzickova, J. et al.-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue. Lipids 39, 1177-1185 (2004).
213. Jump, D. B. Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr. Opin. Lipidol. 13, 155-164 (2002).
214. White, P. J. et al. Transgenic-3 PUFA enrichment alters morphology and gene expression profile in adipose tissue of obese mice: potential role for protectins. Metabolism 64, 666-676 (2015).
215. Ailhaud, G., Guesnet, P. & Cunnane, S. C. An emerging risk factor for obesity: does disequilibrium of polyunsaturated fatty acid metabolism contribute to excessive adipose tissue development? Br. J. Nutr. 100, 461-470 (2008).
216. Levy, J. R., Clore, J. N. & Stevens, W. Dietary-3 polyunsaturated fatty acids decrease hepatic triglycerides in Fischer 344 rats. Hepatology 39, 608-616 (2004).
217. Gould, J. F., Smithers, L. G. & Makrides, M. The effect of maternal-3 (-3) LCPUFA supplementation during pregnancy on early childhood cognitive and visual development: a systematic review and meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 97, 531-544 (2013).
218. Willemsen, R. H. et al. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial. Clin. Endocrinol. (Oxf.) 67, 485-492 (2007).